Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

Skin disease due to viruses may be a primary infection of the epidermis or may arise
secondary to systemic infection. Depending on the virus, the effects may be necrotic damage …

We currently have the knowledge and experience to prevent much of human papillomavirus
(HPV)-related disease burden globally. In many countries where prophylactic HPV …

Background The extent of cross-protection provided by currently licensed bivalent and
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …

Sexually transmitted infections (STIs) are a major public health concern. The UK has some
of the most advanced STI surveillance systems globally. This article uses national …

Objectives The 1916 Royal Commission on Venereal Diseases was established in response
to epidemics of syphilis and gonorrhoea in the UK. In the 100 years since the Venereal …

We analyzed human papillomavirus (HPV) prevalences during prevaccination and
postvaccination periods to consider possible changes in nonvaccine HPV genotypes after …

In 2018, WHO called for global action to eliminate cervical cancer. The complexity of the
processes involved in terms of prevention is often underestimated. Low‐and middle‐income …

Background Human papillomavirus (HPV) is the most widespread sexually transmitted
infection worldwide. It causes several health consequences, in particular accounting for the …